Clinical Trial Update: PD-L1 Targeting Peptide Probe for PET Imaging of Solid Tumor

View source ↗

Summary

A clinical trial update describes a PD-L1–targeting peptide probe for PET imaging of solid tumors, with not-yet-recruiting status and conditions including non-s…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma
• Non-small Cell Lung Cancer
• Small Cell Lung Cancer

Snippet

Sponsor: Peking University Cancer Hospital & Institute | Conditions: Lung Cancer (NSCLC), Lung Cancer (SCLC) | Status: NOT_YET_RECRUITING